Free Trial

AEON Biopharma (AEON) Institutional Ownership

→ The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad)
Free AEON Stock Alerts
$1.73
+0.07 (+4.22%)
(As of 05/10/2024 08:54 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media

Institutional Ownership Changes (13F Filings) for AEON Biopharma (NASDAQ:AEON)

Current
Institutional Ownership
Percentage
22.78%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$27.31M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$44.05K
Get AEON Insider Trade Alerts

Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AEON Biopharma Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008%
2/7/2024Formidable Asset Management LLC58,193$419K0.1%-9.5%0.157%
11/9/2023Formidable Asset Management LLC64,311$360K0.1%N/A0.723%
11/6/2023Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283%
(Data available from 1/1/2016 forward)

AEON Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AEON shares?

During the previous two years, the following institutional investors and hedge funds held shares of AEON Biopharma shares: Atalaya Capital Management LP ($19.83M), and Vanguard Group Inc. ($8.80M), Formidable Asset Management LLC ($419K).Learn more on AEON's institutional investors.

What percentage of AEON Biopharma stock is owned by institutional investors?

22.78% of AEON Biopharma stock is owned by institutional investors. Learn more on AEON's institutional investor holdings.

Which institutional investors have been buying AEON Biopharma stock?

The following institutional investors have purchased AEON Biopharma stock in the last 24 months: Atalaya Capital Management LP ($3.68M), Vanguard Group Inc. ($549.21K), and Formidable Asset Management LLC ($64.31K).

How much institutional buying is happening at AEON Biopharma?

Institutional investors have bought a total of 4,288,518 shares in the last 24 months. This purchase volume represents approximately $27.31M in transactions.

Which AEON Biopharma major shareholders have been selling company stock?

The following institutional investors have sold AEON Biopharma stock in the last 24 months: Formidable Asset Management LLC ($6.12K).

How much institutional selling is happening at AEON Biopharma?

Institutional investors have sold a total of 6,118 shares in the last 24 months. This volume of shares sold represents approximately $44.05K in transactions.


Related Companies:
This page (NASDAQ:AEON) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners
Bill Clinton Backing Biden Replacement???
The Freeport Society
The Department of Defense Has a New Drone Contractor
The Tomorrow Investor
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The Crypto 9-5 Escape Plan
Crypto 101 Media
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
Protect Your Bank Account Before It’s Too Late
Weiss Ratings